Synergy Pharmaceuticals (FRA:S90) Ending Cash Position : €39.12 Mil (As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Ending Cash Position?

Synergy Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2018 was €39.12 Mil.

Synergy Pharmaceuticals's quarterly Ending Cash Position declined from Mar. 2018 (€80.01 Mil) to Jun. 2018 (€52.42 Mil) and declined from Jun. 2018 (€52.42 Mil) to Sep. 2018 (€39.12 Mil).

Synergy Pharmaceuticals's annual Ending Cash Position increased from Dec. 2015 (€56.60 Mil) to Dec. 2016 (€78.10 Mil) and increased from Dec. 2016 (€78.10 Mil) to Dec. 2017 (€115.75 Mil).

Synergy Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Synergy Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Ending Cash Position Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Ending Cash Position

Get a 7-Day Free Trial

13.24

118.79

56.60

78.10

115.75

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Ending Cash Position	Get a 7-Day Free Trial															98.82	115.75	80.01	52.42	39.12

Synergy Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Synergy Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2017 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	69.616	+	46.137
	=	115.75

Synergy Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2018 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	52.476	+	-13.357
	=	39.12

Synergy Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines